Location History:
- Halle/Saale, DE (2006)
- Halle, DE (2007)
Company Filing History:
Years Active: 2006-2007
Title: Susanne Manhart: Innovator in Metabolic Disorder Treatments
Introduction
Susanne Manhart is a notable inventor based in Halle, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of prodrugs for the treatment of metabolic disorders. With a total of 2 patents, her work has the potential to impact the lives of many individuals suffering from various health conditions.
Latest Patents
Manhart's latest patents focus on prodrugs of dipeptidyl peptidase IV (DP IV) inhibitors. These prodrug compounds are designed to be unstable inhibitors of the serine peptidase dipeptidyl peptidase IV. They are utilized in the treatment of a range of disorders, especially metabolic disorders. The prodrug compounds can be effective in treating impaired glucose tolerance, glucosuria, hyperlipidaemia, metabolic acidoses, diabetes mellitus, diabetic neuropathy, and nephropathy.
Career Highlights
Throughout her career, Susanne Manhart has worked with various companies, including Probiodrug AG and Prosidion Limited. Her expertise in the pharmaceutical industry has allowed her to develop innovative solutions that address critical health issues.
Collaborations
Manhart has collaborated with esteemed colleagues such as Hans-Ulrich Demuth and Dagmar Schlenzig. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Susanne Manhart's contributions to the field of metabolic disorder treatments through her innovative prodrug compounds highlight her role as a significant inventor. Her work continues to pave the way for advancements in pharmaceutical therapies.